Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea

BACKGROUND: Previous studies have indicated that ramosetron, a 5-hydroxytryptamine-3 receptor antagonist, achieves global improvement in irritable bowel syndrome (IBS) symptoms in male patients with IBS with diarrhea (IBS-D). However, in addition to global assessment it was deemed important to asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Ida, Motoko, Nishida, Akito, Akiho, Hiraku, Nakashima, Yoshihiro, Matsueda, Kei, Fukudo, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346243/
https://www.ncbi.nlm.nih.gov/pubmed/28293280
http://dx.doi.org/10.1186/s13030-017-0092-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346243/
https://www.ncbi.nlm.nih.gov/pubmed/28293280
http://dx.doi.org/10.1186/s13030-017-0092-x

Ejemplares similares